Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
Détails
ID Serval
serval:BIB_49D46F2161CE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
Périodique
Journal of the National Cancer Institute
Collaborateur⸱rice⸱s
International Breast Cancer Study Group (IBCSG)
ISSN
0027-8874 (Print)
ISSN-L
0027-8874
Statut éditorial
Publié
Date de publication
2002
Volume
94
Numéro
14
Pages
1054-1065
Langue
anglais
Notes
Publication types: Clinical Trial ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.S. Leyvraz membre du International Breast Cancer Study Group
Mots-clé
Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/therapy, Chemotherapy, Adjuvant, Cyclophosphamide/administration & dosage, Endocrine System/drug effects, Fluorouracil/administration & dosage, Humans, Lymphatic Metastasis/prevention & control, Methotrexate/administration & dosage, Middle Aged, Postmenopause, Quality of Life, Tamoxifen/therapeutic use, Tamoxifen/toxicity, Time Factors, Treatment Outcome
Pubmed
Web of science
Création de la notice
08/10/2011 18:29
Dernière modification de la notice
24/11/2023 8:13
Données d'usage
